Efficacy of entecavir versus tenofovir disoproxil fumarate in preventing hepatocellular carcinoma-The jury is out

被引:0
|
作者
Peng, Cheng-Yuan [1 ,2 ,3 ]
机构
[1] China Med Univ Hosp, Ctr Digest Med, Dept Internal Med, Taichung, Taiwan
[2] China Med Univ, Sch Med, Taichung, Taiwan
[3] China Med Univ Hosp, Ctr Digest Med, Dept Internal Med, 2 Yude Rd, Taichung 404332, Taiwan
关键词
CHRONIC HEPATITIS-B; RISK;
D O I
10.1002/aid2.13391
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:5 / 7
页数:3
相关论文
共 50 条
  • [31] Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
    Lim, Young-Suk
    Chan, Henry L. Y.
    Ahn, Sang Hoon
    Seto, Wai Kay
    Ning, Qin
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin Q.
    Chuang, Wan Long
    Izumi, Namiki
    Fung, Scott
    Shalimar, Maurizia
    Brunetto, Maurizia
    Hui, Aric Josun
    Chang, Ting-Tsung
    Lim, Seng Gee
    Abramov, Frida
    Flaherty, John F.
    Wang, Hongyuan
    Yee, Leland J.
    Kao, Jia-Horng
    Gane, Edward
    Hou, Jinlin
    Buti, Maria
    JHEP REPORTS, 2023, 5 (10)
  • [32] Comparison of the efficacy of tenofovir disoproxil fumarate and entecavir for initial treatment of patient with chronic hepatitis B in China
    Huang, Mingxing
    Jie, Yusheng
    Shi, Hong
    Li, Xinhua
    Li, Xiangyong
    Wu, Yuankai
    Lin, Guoli
    Chong, Yutian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (01): : 666 - 673
  • [33] A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
    Wassner, Chanie
    Bradley, Nicole
    Lee, Yuman
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2020, 19
  • [34] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive Asian adults
    Oka, Shinichi
    Chetchotisakd, Ploenchan
    Clarke, Amanda
    Supparatpinyo, Khuanchai
    Kiertiburanakul, Sasisopin
    Ryu, Julie
    Piontkowsky, David
    Guo, Susan
    Nguyen-Cleary, Thai
    Das, Moupali
    McCallister, Scott
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [35] Tenofovir alafenamide versus tenofovir disoproxil fumarate is there a true difference in safety?
    Pepperrell, T.
    Hughes, S.
    Gotham, D.
    Pozniak, A.
    Boffito, M.
    Pilkington, V.
    Hill, A.
    HIV MEDICINE, 2019, 20 : 92 - 92
  • [37] Risk of hepatocellular carcinoma after curative treatment when switching from Tenofovir Disoproxil Fumarate or Entecavir to Tenofovir Alafenamide: a real-world multicenter cohort study
    Shin, Hyunjae
    Ko, Yunmi
    Park, Youngsu
    Kim, Yoon Jun
    JOURNAL OF HEPATOLOGY, 2024, 80 : S798 - S798
  • [38] Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study
    Shin, Hyunjae
    Kim, Seung Up
    Song, Byeong Geun
    Park, Youngsu
    Ko, Yunmi
    Park, Jeayeon
    Hur, Moon Haeng
    Lee, Yun Bin
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Yoon, Jung-Hwan
    Sinn, Dong Hyun
    Kim, Yoon Jun
    HEPATOLOGY RESEARCH, 2024, 54 (07) : 627 - 637
  • [39] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
    Lee, Hye Won
    Cho, Young Youn
    Lee, Hyein
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Park, Soo Young
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (11) : 1570 - 1578
  • [40] Original Article Clinical effectiveness of entecavir versus tenofovir disoproxil fumarate tablets in chronic hepatitis B treatment
    Zhou, You
    Shen, Yanyan
    He, Jian
    Yang, Xuefeng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (12): : 7591 - 7599